Nachrichten zur Biogen Inc. Aktie

Biogen (BIIB) Weighs Takeover of Drugmaker Reata (RETA)

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biogen to buy Reata for $6.5 billion to bulk up rare disease portfolio

...(Reuters) - Biogen said it would buy biotech firm Reata......…

UPDATE 2-Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio

... paragraph) July 28 (Reuters) - Biogen said it would buy biotech firm......…

Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion in cash

Biogen Inc. BIIB said Friday it has agreed to acquire Reata Pharmaceuticals Inc. RETA for $7.3 billion in cash. …

Biogen agrees to buy Reata Pharmaceuticals for $172.50 a share in cash

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K BIOGEN INC. For: Jul 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biogen to Acquire Reata Pharmaceuticals

CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Reata Pharmaceuticals,…

I Was Concerned About Biogen Until I Heard These 11 Words From Its CEO

Biogen shares have stagnated in recent years, but the company has a plan to change that....…

Biogen: Kursziel angehoben

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Needham & Co stufen die Aktie von Biogen Inc. (ISIN: US09062X1037, WKN: 789617,…

Analyst Ratings for Biogen

Latest Ratings for BIIB DateFirmActionFromTo Mar 2022StifelDowngradesBuyHold Mar 2022RBC CapitalUpgradesSector PerformOutperform Feb 2022Canaccord GenuityMaintainsBuy View…

Biogen: Unterbewertet - Aktienanalyse

St. Louis (www.aktiencheck.de) - Biogen-Aktienanalyse von Stifel: Paul Matteis, Analyst von Stifel, rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der…

Biogen: Mangel an Klarheit - Kursziel gesenkt - Aktienanalyse

Charlotte (www.aktiencheck.de) - Biogen-Aktienanalyse von BofA Securities: Die Analysten von BofA Securities senken das Kursziel für die Aktie von Biogen Inc.…

Why Biogen Stock Got Sick Today

While the company has won approval for a promising drug, its cutting costs in the wake of that regulatory green…

Form 10-Q BIOGEN INC. For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biogen (BIIB) Q2 2023 Earnings Call Transcript

BIIB earnings call for the period ending June 30, 2023....…

Biogen (BIIB) Beats on Q2 Earnings & Sales, Announces Job Cuts

Biogen (BIIB) beats second-quarter estimates for earnings and sales. It maintains 2023 guidance. Stock up in pre-market....…

2023 Layoff Tracker: Biogen Cuts 1,000 Employees

Second quarter layoffs continue apace after more than 136,000 employees were cut by major U.S. companies in the first quarter…

Biogen Stock Drops Despite News of Layoffs as Company Rolls Out Alzheimers Drug

The company is reducing its staff by about 11%, in a cost-cutting effort it expects it will save $1 billion…

Biogen to Cut Roughly 11% of Workforce

The biotech cited the launch of Alzheimers drug Leqembi as part of its new focus on big-return products....…

Biotechkonzern: Biogen streicht 1000 Stellen wegen Markteinführung von Alzheimermittel

Anfang Juli hatten die US-Behörden das Medikament Leqembi vollständig zugelassen. Biogen streicht nun andere Projekte, um sich auf das Mittel…

Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch

Biogen, in its second-quarter earnings report, said the plan will result in $700 million in net operating expense savings by…

Biogen Q2 Results Top Estimates; Backs FY23 Outlook

WESTON (dpa-AFX) - Biotechnology company Biogen, Inc. (BIIB) reported Tuesday that net income attributable to the company for the second…

Biogen tops earnings estimates and says it will shift resources to higher value areas

Biogen Inc.’s stock BIIB rose 1.1% premarket Tuesday, after the company swept past earnings estimates for the second quarter and…

Biogen Non-GAAP EPS of $4.02 beats by $0.26, revenue of $2.46B beats by $100M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K BIOGEN INC. For: Jul 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sensation: Vollständige Krebsheilung - Massives Kaufsignal. Neuer 202% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensation: Vollständige Krebsheilung - Massives Kaufsignal. 202% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX) 25.07.23 08:02AC Research London (www.aktiencheck.de, Anzeige) Link zum Report:......…

Biogen Q2 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Better Big Biotech Buy: Vertex vs. Biogen

These companies have a track record of billion-dollar earnings....…

Lilly Joins Biogen as Alzheimer’s Drugs Finally Emerge

In trials, Biogen and Eli Lilly have shown that their drugs can slow early-stage decline in the disease. It could…

Final Trades: Charles Schwab, Biogen & more

The "Halftime Report" traders give their top picks to watch for the second half....…

Is Biogen Stock a Buy Now?

The biotech hasnt been the best investment recently....…

Alzheimers Drugs May Be a Big-Pharma Payday. Lilly and Biogen Are Facing Off.

Two similar Alzheimer’s drugs are likely to be on the market and accessible for Medicare patients sometime in 2024....…

Biogen, Eli Lilly likely to split the Alzheimer’s drug market, analysts say

Eli Lilly and Co. LLY and Biogen Inc. BIIB are likely to reach an “equitable split” of the Alzheimer’s drug…

Eli Lilly expects FDA decision on Alzheimers treatment donanemab by the end of the year

Eli Lilly is racing to market donanemab for Alzheimers after Eisai and Biogens drug for the disease, Leqembi, won FDA…

Should You Buy the Dip With Biogen Stock Right Now?

Its expected to grow, but things might not work out precisely as planned....…

These 2 Numbers Should Scare Every Biogen Shareholder

There are a couple of pieces of evidence that Biogens long-term strategy isnt working....…

Roche reicht in USA Klage gegen Biogen wegen Actemra-Nachahmermedikament ein

Pharma - Roche wirft dem US-Biotechunternehmen Biogen vor, mehrere seiner Patente verletzt zu haben.temra mehrere seiner US-Patente verletzt zu haben....…

Biogen: Neues Kursziel

Toronto (www.aktiencheck.de) - Rating-Update: RBC Capital Markets stuft die Aktie von Biogen Inc. (ISIN: US09062X1037, WKN: 789617, Ticker-Symbol: IDP, NASDAQ-Symbol: BIIB)…

Dow & Co geben nach: Chevron, Schlumberger, Halliburton, Lucid Group, Alibaba und Newmont Mining stark, Verizon und Biogen Idec deutlich unter Druck – der Tag an der Wall Street

Der mit Spannung erwartete US-Arbeitsmarktbericht für Juni hat am Freitag die US-Börsen nicht anschieben können. Er hielt zwar Positives wie…

XETR : US09062X1037: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

Three-Stock Lunch: Meta, Biogen and Levi Strauss

Gina Sanchez, chief market strategist at Lido Advisors, joins Power Lunch to discuss her thoughts on three stocks: Meta, Biogen…

Biogens Alzheimers Drug Rollout Could Be Slow

Biogen has said it doesn't expect to clear a profit on Alzheimer's treatment Leqembi, which was approved by the FDA…

Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more

These are the stocks posting the largest moves in midday trading....…

Blitz-Update: Dow & Co nach Arbeitsmarktdaten kaum verändert, Alibaba, Caterpillar und Enphase Energy stark, Meta, Merck & Co, Amgen und Biogen Idec unter Druck

Die US-Börsen haben am Freitag auf den US-Arbeitsmarktbericht für Juni als das konjunkturelle Highlight der Woche mit Stagnation reagiert. Die…

dpa-AFX ProFeed